Collegium Pharmaceutical (COLL) Intangibles (2018 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Intangibles of $614.0 million for Q1 2026, down 26.54% year-over-year from $835.9 million in Q1 2025, and down 8.29% quarter-over-quarter from $669.5 million in Q4 2025.
Collegium Pharmaceutical (COLL) Intangibles (2018 - 2026) Analysis & Trends
Collegium Pharmaceutical's Intangibles history runs 7 years deep, the most recent figure standing at $614.0 million for Q1 2026.
- In Q1 2026, Intangibles fell 26.54% year-over-year to $614.0 million; the TTM figure through Mar 2026 stood at $614.0 million (down 26.54% YoY), while the FY2025 annual figure was $669.5 million, down 24.89% from the prior year.
- Intangibles for Q1 2026 stood at $614.0 million, down from $669.5 million in the prior quarter.
- The five-year high for Intangibles was $966.2 million in Q1 2022, with the low at $352.7 million in Q2 2024.
- The 5-year median for Intangibles is $725.0 million (2025), against an average of $704.2 million.
- The sharpest annual moves came in 2024 and 2025: Intangibles slumped 59.29% in 2024, then surged 121.3% in 2025.
- Collegium Pharmaceutical's Intangibles stood at $567.5 million in 2022, then fell by 25.69% to $421.7 million in 2023, then jumped by 111.38% to $891.4 million in 2024, then slipped by 24.89% to $669.5 million in 2025, then slipped by 8.29% to $614.0 million in 2026.
- Business Quant data shows COLL's Intangibles at $614.0 million in Q1 2026, $669.5 million in Q4 2025, and $725.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.12 Bn |
| 10 | Collegium Pharmaceutical | 887.15 Mn | 737.84 Mn | 110.29 Mn | 1.19 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.19 Bn |
| Mar 31, 2026 | 614.04 Mn |
| Dec 31, 2025 | 669.51 Mn |
| Sep 30, 2025 | 724.98 Mn |
| Jun 30, 2025 | 780.46 Mn |
| Mar 31, 2025 | 835.93 Mn |
| Dec 31, 2024 | 891.40 Mn |
| Sep 30, 2024 | 946.88 Mn |
| Jun 30, 2024 | 352.68 Mn |
| Mar 31, 2024 | 387.19 Mn |
| Dec 31, 2023 | 421.71 Mn |
| Sep 30, 2023 | 456.22 Mn |
| Jun 30, 2023 | 492.54 Mn |
| Mar 31, 2023 | 951.17 Mn |
| Dec 31, 2022 | 567.47 Mn |
| Sep 30, 2022 | 956.17 Mn |
| Jun 30, 2022 | 956.17 Mn |
| Mar 31, 2022 | 966.17 Mn |
| Dec 31, 2021 | 521.17 Mn |
| Dec 31, 2018 | 154.09 Mn |